Israel’s Teva has partnered with the US/Israeli firm Perrigo to launch “a high quality, less expensive alternative” to Temodar (temozolomide) for the treatment of adult patients with newly diagnosed glioblastoma multiforme (brain tumor). Teva also had good news about its chemotherapy and prostate cancer treatments.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000871415&fid=1725
http://www.globes.co.il/serveen/globes/docview.asp?did=1000870562&fid=1725